NR 603 Pulmonary Case Part 1

NR 603 Pulmonary Case Part 1

NR 603 Pulmonary Case Part 1

My primary diagnosis for this patient is asthma. According to Agarwal et al. (2015), healthcare providers should suspect asthma if a patient presents with symptoms such as episodic or recurrent breathlessness, cough, wheezing, and/or chest tightness caused by unexplained alternative. There exist a number of risk factors for asthma. They include aspects such as age, gender, atopy, history of the disease, occupational exposure, and biomass exposure. The patient presented with symptoms that are suggestive of asthma. For instance, symptoms such as occasional chest tightness in the patient could point towards a possible diagnosis of asthma. There is also a high risk of exposure to environmental allergens. The symptoms become evident only when in the workplace.  The client also has history of asthma, which might have recurred. Pulmonary function test remains an effective method for diagnosing asthma. According to Ballas (2018), asthma is diagnosed if the findings of pulmonary function test are lower than the normal value. Therefore, there is a possible diagnosis of diabetes in the patient since the results of pulmonary function test is lower than the normal value.

The first line of treatment that I would consider in managing the patient’s condition is inhaled corticosteroid. An

NR 603 Pulmonary Case Part 1
NR 603 Pulmonary Case Part 1

example of an inhaled corticosteroid that I would prescribe for the patient is Budesonide 200 micro-milligrams once a day. The drug works by suppressing the inflammation of the airways, which cause symptoms of asthma (Agarwal et al., 2015). There is no need to prescribe the patient any reliever medication since there are no complaints of severe chest tightness. Spirometry can be requested to confirm the diagnosis of the disease. The client needs to be referred to an asthma specialist for further care. The health education to be shared with the client include the importance of medical adherence, avoidance of possible allergens, avoiding engaging in excessive exercises, and side effects of the prescribed medication. The use of antibiotics is not recommended in the management of asthma (White et al., 2018). However, they can be used in cases of asthma complications to minimize bacterial infections. Therefore, I will inform the patient that the disease process is managed by the use of inhaled corticosteroid and avoidance of environmental allergens.

 

Click here to ORDER an A++ paper from our Verified MASTERS and DOCTORATE WRITERS: NR 603 Pulmonary Case Part 1

References

Agarwal, R., Dhooria, S., Aggarwal, A. N., Maturu, V. N., Sehgal, I. S., Muthu, V., … & Jindal, S. K. (2015). Guidelines for diagnosis and management of bronchial asthma: Joint ICS/NCCP (I) recommendations. Lung India: official organ of Indian Chest Society32(Suppl 1), S3.

Ballas, Z. K. (2018). Asthma clinical practice guidelines: Time for an update. Journal of Allergy and Clinical Immunology142(3), 787.

White, J., Paton, J. Y., Niven, R., & Pinnock, H. (2018). Guidelines for the diagnosis and management of asthma: A look at the key differences between BTS/SIGN and NICE. Thorax73(3), 293-297.